Dymon Asia Capital (Singapore)’s GSK GSK Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60,200	Closed	-$3.32M	–	274
2026 Q1	$3.32M	Buy	+60,200	New	+$3.26M	0.34%	84
2025 Q4	–	Sell	-40,000	Closed	-$1.73M	–	279
2025 Q3	$1.73M	Buy	40,000 +13,500	+51%	+$527K	0.18%	118
2025 Q2	$1.02M	Buy	26,500 +8,500	+47%	+$325K	0.14%	114
2025 Q1	$697K	Buy	+18,000	New	+$659K	0.16%	96

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s GSK Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) sold out of GSK (GSK) in Q2 2026, closing a stake of 60,200 shares — an estimated $3.32M sold.

Dymon Asia Capital (Singapore) first reported a position in GSK in Q1 2025 and held it in 4 quarters. The position peaked at $3.32M in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Dymon Asia Capital (Singapore) reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Dymon Asia Capital (Singapore) sold 60,200 GSK shares in Q2 2026, an estimated $3.32M.
Dymon Asia Capital (Singapore) first reported a position in GSK in Q1 2025 and held it in 4 quarters.
Dymon Asia Capital (Singapore)'s GSK position peaked at $3.32M in Q1 2026.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.